Benzodiazepines belong to a group of substances well known for their sedative, hypnotic and anticonvulsant properties and they are used worldwide for the therapy of anxiety, sleep disorders and convulsive attacks [1]. Benzodiazepines are among the most commonly drugs today and are often found in a combination with other drugs in drug-related fatalities [1, 2]. Therefore, it is essential for a laboratory to develop a rapid method for the detection of this class compounds.
Gas chromatography with negative ion chemical ionization mass spectrometry (GC/NICI-MS) is a sensitive and selective technique for the analysis of benzodiazepines [3, 4]. The mechanism of NICI is characterized as a "soft" ionization technique, whereby NICI spectra exhibit information about prominent molecular anions and therefore about their molecular weight. This method enables to reach the highest specificity for these analytes and meet the requirements of good laboratory practice.
Therefore, the main aim of study was to develop and validate a new sensitive and specific method based on GC/NICI-MS using mixed-mode solid phase extraction for the determination of these drugs in whole blood. To the best of my knowledge, this method has been used for the first time for the optimization of sample preparation at pH 1.0. Analytical methods in clinical and forensic toxicology may either be used for screening and identification of benzodiazepines in biological fluids or for their quantification in these matrices, or in both cases. For the quantitative bioanalytical procedures there is a general agreement that at least the following validation parameters should be evaluated: the limit of detection (LOD) and quantification (LOQ), selectivity, calibration model (linearity), accuracy, precision (RSD), recovery, robustness and stability [3, 5, 6, 7]. The reliability of this method was certified by means of an exhaustive validation study.
The presented method has several advantages when compared with other previously published data [3, 4, 8, 9]. The LOD and LOQ for 15 benzodiazepines in whole blood samples for the developed method were in the range of 0.24 – 0.62 ng mL-1 and 0.72 – 1.89 ng mL-1, respectively. The linear relationships with the coefficient of determination (r2) were in the range from 0.9961 to 0.9997.
Furthermore, no interferences were observed from the tested substances at the retention times of 15 benzodiazepines. The results of intraday and interday accuracy test for three different concentrations of analyte were in the range of 89.5 – 110.5 %, while all RSDs (precision) for replicate determinations were in the range of 4.08 - 9.52%. Moreover, it was determined that extraction efficiency ranged from 82.9 (±6.2) % to 94.6 (±3.4) %. The absolute recoveries for most of the analytes ranged from 80.6 to 91.4%, except for oxazepam (70.8%), lorazepam (62.2 %), clonazepam (61.8%) and $\alpha$-OH-alprazolam (61.1%). It was shown that conservation at ambient temperature (22.5 ± 0.5 °C) up to 50 h did not significantly alter analytical results. The stability of tested samples ranged from 84.6 to 115.5%, and the precision was less than 12.4 %. Moreover, this method has several advantages: elimination of interferences, low-volume of samples (0.2 mL), a multi-residue analysis, and very fast chromatographic separation of fifteen analytes. Sensitive and specific NICI-MS detection combined with various characteristic fast GC parameters resulted in sharp and symmetric peaks shape of the analytes in chromatographic separation lasting for 3.9 min, while still maintaining sufficient resolution.
Obtained results showed, that the developed mixed-mode solid phase extraction method is accurate, sensitive, selective and specific enough to detect analytes after a long time of a single oral administration of some drugs using GC/NICI-MS. Finally, it was demonstrated, that this method is applicable for the determination of trace concentrations of benzodiazepines in real whole blood samples. The developed method can be applied in routine toxicological analysis during the investigations of both clinical and forensic cases.